Results from a Phase 3 study show that patients with metastatic breast cancer who were treated previously with an anthracycline in the adjuvant setting experienced a significant improvement in time to disease progression (TTP) and overall response rates after receiving a combination of Doxil (doxorubicin HCl liposome injection) and docetaxel as compared to docetaxel alone.
Full Post: Doxil and docetaxel combination treatment delays disease progression in metastatic breast cancer
A study published next week in the open access journal PLoS Medicine suggests that elderly people with damaged kidneys are at greater risk of cardiovascular disease, such as heart failure and stroke, and other causes of mortality.
The findings indicate that greater efforts should be made to encourage elderly people who have impaired kidney function alongside other risk factors-such as high blood cholesterol and high blood pressure, which are often a result of smoking and diet-to make lifestyle changes to avoid developing cardiovascular problems.
Most countries face increasing rates of cardiovascular disease and it is the single leading cause of death in the United States and many European countries. It has already been established that young and middle-aged people with a reduced estimated glomerular filtration rate (eGFR)-the measurement of the movement of waste and excess fluid through the kidneys-are more likely to develop cardiovascular disease than those with healthy kidneys. To establish how at risk elderly people with impaired kidney function were, Ian Ford of the University of Glasgow and colleagues analysed existing data from a three year clinical trial conducted among men and women aged between 70 and 82 in Scotland, Ireland and the Netherlands.
The trial-known as the Prospective Study of Pravastatin in the Elderly at Risk, or PROSPER trial-had been designed to test the effect of the statin pravastatin on the development of cardiovascular disease. Dividing the trial participants into four groups based on their eGFR at the start of the study, Ian Ford and colleagues established that the patients with a low eGFR-those with the most impaired kidney function-were twice as likely to die from any cause as those with healthier kidneys. They also established that the patients with the most damaged kidneys were three times more likely to have non-fatal heart failure or disease and were more likely to die as a result of heart disease or failure.
The data also showed that treatment with the drug pravastatin reduced the number of fatal and non-fatal heart problems more effectively amongst the group of patients with the most damaged kidneys-although the researchers warn that this finding is statistically borderline and say the most that can be concluded is that there is no reason to exclude elderly people with damaged kidneys from treatment with statins, the drugs that reduce blood cholesterol levels in those at risk of cardiovascular disease.
http://www.plos.org/
--------------------------------------------------------------------------------------------
Related Posts:
Cold weather may raise blood pressure in elderly. In new research French are suggesting that elderly people may be more at risk of suffering a stroke, heart attack or kidney failure in winter because cold weather may raise their blood pressure. The researchers from the National Institute of Health and Medical Research in Paris say
Full Post: Elderly more at risk of heart attack in cold weather
Heart failure is reaching epidemic levels among seniors in the United States, according to research presented at the American Heart Association’s Scientific Sessions 2008. “Both the number of patients hospitalized with a primary diagnosis of heart failure and age-adjusted hospitalization rates for heart failure have increased dramatically over the past 27 years,” said Longjian Liu,
Full Post: Heart failure hospitalization rates rise among nation’s seniors
Older adults who take the diabetes medication rosiglitazone appear to have a higher risk of death and heart failure than those taking the related medication pioglitazone, according to a report in the November 24 issue of Archives of Internal Medicine. In 1997, a new class of oral medications known as thiazolidinediones expanded the available options
Full Post: Risks associated with diabetes drug rosiglitazone may be higher than those with pioglitazone
Chronic kidney disease (CKD) exacts a significant toll on a woman’s sexuality and gynecologic health. The various effects of kidney failure and its treatments on women’s sexual health from adolescence through menopause will be the topic of an in-depth series of presentations at the American Society of Nephrology’s 41st Annual Meeting and Scientific Exposition in
Full Post: Chronic kidney disease and women’s sexuality and gynecologic health
A Johns Hopkins study finds that HIV-positive kidney transplant recipients could have the same one-year survival rates for themselves and their donor organs as those without HIV, provided certain risk factors for transplant failure are recognized and tightly managed. “Kidney transplantation is a viable and necessary option for HIV-positive patients with chronic kidney disease, especially
Full Post: Kidney transplant survival can be long-term for people with HIV --------------------------------------------------------------------------------------------
